Cited by 3,762Cytokine Signaling Pathways and InteractionsImmune Response and InflammationImmune cells in cancer

The DOI matches its Crossref record; 41 of the 41 references it cites were found in a registry or an index.

Interleukin 10(IL-10) inhibits cytokine synthesis by human monocytes: an autoregulatory role of IL-10 produced by monocytes.

Open access

de Waal Malefyt, R, Abrams, J, Bennett, B, Figdor, C G, de Vries, J E·1991·The Journal of experimental medicine

DOI 10.1084/jem.174.5.1209PMC PMC2119001

Open this paper in CoChat — free account

Abstract

In the present study we demonstrate that human monocytes activated by lipopolysaccharides (LPS) were able to produce high levels of interleukin 10 (IL-10), previously designated cytokine synthesis inhibitory factor (CSIF), in a dose dependent fashion. IL-10 was detectable 7 h after activation of the monocytes and maximal levels of IL-10 production were observed after 24-48 h. These kinetics indicated that the production of IL-10 by human monocytes was relatively late as compared to the production of IL-1 alpha, IL-1 beta, IL-6, IL-8, tumor necrosis factor alpha (TNF alpha), and granulocyte colony-stimulating factor (G-CSF), which were all secreted at high levels 4-8 h after activation. The production of IL-10 by LPS activated monocytes was, similar to that of IL-1 alpha, IL-1 beta, IL-6, IL-8, TNF alpha, granulocyte-macrophage colony-stimulating factor (GM-CSF), and G-CSF, inhibited by IL-4. Furthermore we demonstrate here that IL-10, added to monocytes, activated by interferon gamma (IFN-gamma), LPS, or combinations of LPS and IFN-gamma at the onset of the cultures, strongly inhibited the production of IL-1 alpha, IL-1 beta, IL-6, IL-8, TNF alpha, GM-CSF, and G-CSF at the transcriptional level. Viral-IL-10, which has similar biological activities on human cells, also inhibited the production of TNF alpha and GM-CSF by monocytes following LPS activation. Activation of monocytes by LPS in the presence of neutralizing anti-IL-10 monoclonal antibodies resulted in the production of higher amounts of cytokines relative to LPS treatment alone, indicating that endogenously produced IL-10 inhibited the production of IL-1 alpha, IL-1 beta, IL-6, IL-8, TNF alpha, GM-CSF, and G-CSF. In addition, IL-10 had autoregulatory effects since it strongly inhibited IL-10 mRNA synthesis in LPS activated monocytes. Furthermore, endogenously produced IL-10 was found to be responsible for the reduction in class II major histocompatibility complex (MHC) expression following activation of monocytes with LPS. Taken together our results indicate that IL-10 has important regulatory effects on immunological and inflammatory responses because of its capacity to downregulate class II MHC expression and to inhibit the production of proinflammatory cytokines by monocytes.

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

Integrity signals

Registry

Crossref · 10.1084/jem.174.5.1209

Cites

41 of 41 references verified0 citation errors · 0 not checkable

Statistics

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

A technique for radiolabeling DNA restriction endonuclease fragments to high specific activity
Feinberg, A. P., & Vogelstein, B. (1983) · Analytical Biochemistry · doi:10.1016/0003-2697(83)90418-9 · Cited by 24,512 · cited 1×
“6% formaldehyde, transferred to Nytran nylon membranes (Schleicher & Schuell, Keene, NH) and hybridized with probes, labeled to high specific activity (>10 s cpm//~g) by the hexamer labeling technique (23).”
Isolation of biologically active ribonucleic acid from sources enriched in ribonuclease
Chirgwin, J. M., Przybyla, A., MacDonald, R. J., & Rutter, W. J. (1979) · Biochemistry · doi:10.1021/bi00591a005 · Cited by 21,460 · cited 1×
“Total ILNA was isolated from 20 x 106 monocytes by the guanidinium thioeyanateCsC1 procedure (22).”
Single-step purification of polypeptides expressed in Escherichia coli as fusions with glutathione S-transferase
Smith, D. B., & Johnson, K. S. (1988) · Gene · doi:10.1016/0378-1119(88)90005-4 · Cited by 5,844
Two types of mouse T helper cell. IV. Th2 clones secrete a factor that inhibits cytokine production by Th1 clones.
Fiorentino, D. F., Bond, M. W., & Mosmann, T. R. (1989) · The Journal of Experimental Medicine · doi:10.1084/jem.170.6.2081 · Cited by 2,733
The biology of interleukin-6
Kishimoto, T. (1989) · Blood · doi:10.1182/blood.v74.1.1.bloodjournal7411 · Cited by 2,068
Neutrophil-activating peptide-1/interleukin 8, a novel cytokine that activates neutrophils.
Baggiolini, M., Walz, A., & Kunkel, S. L. (1989) · Journal of Clinical Investigation · doi:10.1172/jci114265 · Cited by 1,975 · cited 1×
“the activation and function of cells of the immune system but also those of endothelial cells, keratinocytes and hepatocytes (42-44), suggests that II.”
Interleukin 10 (IL-10) and viral IL-10 strongly reduce antigen-specific human T cell proliferation by diminishing the antigen-presenting capacity of monocytes via downregulation of class II major histocompatibility complex expression.
Malefyt, R. D. W., Haanen, J. B. A. G., Spits, H., Roncarolo, M., Velde, A. A. T., Figdor, C. G., Johnson, K., KASTELEIN, R. A., Yssel, H., & de Vries, J. E. (1991) · The Journal of Experimental Medicine · doi:10.1084/jem.174.4.915 · Cited by 1,930
Self-citation
IL-10 acts on the antigen-presenting cell to inhibit cytokine production by Th1 cells
Fiorentino, D. F., Zlotnik, A., Vieira, P., Mosmann, T. R., Howard, M., Moore, K. W., & O’Garra, A. (1991) · The Journal of Immunology · doi:10.4049/jimmunol.146.10.3444 · Cited by 1,866
Human tumour necrosis factor: precursor structure, expression and homology to lymphotoxin
Pennica, D., Nedwin, G. E., Hayflick, J. S., Seeburg, P. H., Derynck, R., Palladino, M. A., Kohr, W. J., Aggarwal, B. B., & Goeddel, D. V. (1984) · Nature · doi:10.1038/312724a0 · Cited by 1,732 · cited 2×
“-6 sense primer 5'-ATGAACTCCTTCTCCACAAGC-3' (nt 1 - 21), Ib6 anti sense primer 5'-CTACATTTGCCGAAGAGCCCTCAGGCTGGACTG-3' (nt 810 - 777) (17), Ib8 sense primer 5'-ATGACTTCCAAGCTGGCCGTG-3' (nt 1 - 21), I1-8 anti sense primer 5'-TTATGAATTCTCAGCCCTCTTCAAAAACTTCTC-Y (nt 302 - 269) (15), IL-10 sense primer 5'-ATGCCCCAAGCTGAGA…”
Cloning, sequence and expression of two distinct human interleukin-1 complementary DNAs
March, C. J., Mosley, B., Larsen, A., Cerretti, D. P., Braedt, G., Price, V. L., Gillis, S. A., Henney, C. S., Kronheim, S. R., Grabstein, K. H., et al. (1985) · Nature · doi:10.1038/315641a0 · Cited by 1,559 · cited 2×
“The following oligonucleotides were used for Southern analysis of PCR products: IL-lot: 5'-CATGGGTGCTTATAAGTCATC-Y (nt 500-521) (16); IL-1/3: 5'-CGATCACTGAACTGCACGCTCCGGG-3' (nt 444 469) (16); Ib6: 5'GAGGTATACCTAGAGTACCTC-Y (nt 510 - 531) (17); IL-8: 5'-TAAAGACATACTCCAAACCTT-3' (nt 200 - 221) (15); IL-10: 5'-CAGGTGAAG…”

Show all 41 references

Sorted by citations

Interleukin-10 and the Interleukin-10 Receptor
Moore, K. W., de Waal Malefyt, R., Coffman, R. L., & O'Garra, A. (2001) · Annual Review of Immunology · doi:10.1146/annurev.immunol.19.1.683 · Cited by 6,737
Foreign body reaction to biomaterials
Anderson, J. M., Rodriguez, A., & Chang, D. T. (2008) · Seminars in Immunology · doi:10.1016/j.smim.2007.11.004 · Cited by 5,138
The regulation of IL-10 production by immune cells
Saraiva, M., & O’Garra, A. (2010) · Nature reviews. Immunology · doi:10.1038/nri2711 · Cited by 3,293
Macrophages that have ingested apoptotic cells in vitro inhibit proinflammatory cytokine production through autocrine/paracrine mechanisms involving TGF-beta, PGE2, and PAF.
Fadok, V. A., Bratton, D. L., Konowal, A., Freed, P. W., Westcott, J. Y., & Henson, P. M. (1998) · Journal of Clinical Investigation · doi:10.1172/jci1112 · Cited by 3,166
Development of T H 1 CD4 + T Cells Through IL-12 Produced by Listeria -Induced Macrophages
Hsieh, C.-S., Macatonia, S. E., Tripp, C. S., Wolf, S. F., O'Garra, A., & Murphy, K. M. (1993) · Science · doi:10.1126/science.8097338 · Cited by 3,134
Muscle as an Endocrine Organ: Focus on Muscle-Derived Interleukin-6
Pedersen, B. K., & Febbraio, M. A. (2008) · Physiological Reviews · doi:10.1152/physrev.90100.2007 · Cited by 2,388
Interleukin-8 and related chemotactic cytokines--CXC and CC chemokines.
Baggiolini, M., Dewald, B., & Moser, B. (1994) · PubMed · Cited by 2,232
AN INVESTIGATION OF POLYMORPHISM IN THE INTERLEUKIN‐10 GENE PROMOTER
Turner, D. M., Williams, D. M., Sankaran, D., Lazarus, M. N., Sinnott, P. J., & Hutchinson, I. V. (1997) · European Journal of Immunogenetics · doi:10.1111/j.1365-2370.1997.tb00001.x · Cited by 1,706
lnterleukin-8 and Related Chemotactic Cytokines—CXC and CC Chemokines
Baggiolini, M., Dewald, B., & Moser, B. (1993) · Advances in immunology · doi:10.1016/s0065-2776(08)60509-x · Cited by 1,672
IL-28, IL-29 and their class II cytokine receptor IL-28R
Sheppard, P. O., Kindsvogel, W., Xu, W., Henderson, K., Schlutsmeyer, S., Whitmore, T. E., Kuestner, R. E., Garrigues, U., Birks, C., Roraback, J., et al. (2002) · Nature Immunology · doi:10.1038/ni873 · Cited by 1,563
Interleukin-6 in Biology and Medicine
Akira, S., Taga, T., & Kishimoto, T. (1993) · Advances in immunology · doi:10.1016/s0065-2776(08)60532-5 · Cited by 1,402
Interleukin 10 (IL-10) inhibits human lymphocyte interferon gamma-production by suppressing natural killer cell stimulatory factor/IL-12 synthesis in accessory cells.
D’Andrea, A., Aste-Amézaga, M., Valiante, N. M., Ma, X., Kubin, M. Z., & Trinchieri, G. (1993) · The Journal of Experimental Medicine · doi:10.1084/jem.178.3.1041 · Cited by 1,367
Adiponectin, a new member of the family of soluble defense collagens, negatively regulates the growth of myelomonocytic progenitors and the functions of macrophages
Yokota, T., Oritani, K., Takahashi, I., Ishikawa, J., Matsuyama, A., Ouchi, N., Kihara, S., Funahashi, T., Tenner, A. J., Tomiyama, Y., et al. (2000) · Blood · doi:10.1182/blood.v96.5.1723 · Cited by 1,294
Macrophage deactivation by interleukin 10.
Bogdan, C., Yoram Vodovotz, B., & Nathan, C. (1991) · The Journal of Experimental Medicine · doi:10.1084/jem.174.6.1549 · Cited by 1,236
Inhibition of Thl responses prevents inflammatory bowel disease in scid mice reconstituted with CD45RBhi CD4+ T cells
Powrie, F., Leach, M. W., Mauze, S., Menon, S., Barcomb Caddle, L., & Coffman, R. L. (1994) · Immunity · doi:10.1016/1074-7613(94)90045-0 · Cited by 1,146
Enterocolitis and colon cancer in interleukin-10-deficient mice are associated with aberrant cytokine production and CD4(+) TH1-like responses.
Berg, D., Davidson, N. M., Kühn, R., Müller, W., Menon, S., Holland, G., Thompson-Snipes, L., Leach, M. W., & Rennick, D. M. (1996) · Journal of Clinical Investigation · doi:10.1172/jci118861 · Cited by 1,125
Biology and therapeutic potential of interleukin-10
Saraiva, M., Vieira, P., & O’Garra, A. (2019) · The Journal of Experimental Medicine · doi:10.1084/jem.20190418 · Cited by 1,157
IL-10 Family Cytokines IL-10 and IL-22: from Basic Science to Clinical Translation
Ouyang, W., & O’Garra, A. (2019) · Immunity · doi:10.1016/j.immuni.2019.03.020 · Cited by 1,141
Topical Delivery of Silver Nanoparticles Promotes Wound Healing
Tian, J., Wong, K. K., Ho, C., Lok, C., Yu, W., Che, C., Chiu, J., & Tam, P. K. H. (2006) · ChemMedChem · doi:10.1002/cmdc.200600171 · Cited by 984
Enhanced Th1 activity and development of chronic enterocolitis in mice devoid of Stat3 in macrophages and neutrophils
Takeda, K., Clausen, B. E., Kaisho, T., Tsujimura, T., Terada, N., Förster, I., & Akira, S. (1999) · Immunity · doi:10.1016/s1074-7613(00)80005-9 · Cited by 1,220
Human IL-23-producing type 1 macrophages promote but IL-10-producing type 2 macrophages subvert immunity to (myco)bacteria
Verreck, F. A. W., de Boer, T., Langenberg, D. M. L., Hoeve, M. A., Kramer, M., Vaisberg, E., Kastelein, R., Kolk, A. H. J., Malefyt, R. D. W., & Ottenhoff, T. H. M. (2004) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0400983101 · Cited by 969
Role of interleukin 10 in specific immunotherapy.
Akdiş, C. A., Blesken, T., Akdiş, M., Wüthrich, B., & Blaser, K. (1998) · Journal of Clinical Investigation · doi:10.1172/jci2250 · Cited by 966
Epitope spreading in immune-mediated diseases: implications for immunotherapy
Vanderlugt, C. L., & Miller, S. D. (2002) · Nature reviews. Immunology · doi:10.1038/nri724 · Cited by 947
Interleukin-10 Therapy—Review of a New Approach
Asadullah, K., Sterry, W., & Volk, H. (2003) · Pharmacological Reviews · doi:10.1124/pr.55.2.4 · Cited by 941
Cytokines and the nervous system II: actions and mechanisms of action
Rothwell, N. J., & Hopkins, S. J. (1995) · Trends in Neurosciences · doi:10.1016/0166-2236(95)93890-a · Cited by 922
Inflammatory Markers and Physical Performance in Older Persons: The InCHIANTI Study
Cesari, M., Penninx, B. W. J. H., Pahor, M., Lauretani, F., Corsi, A. M., Williams, G. R., Guralnik, J. M., & Ferrucci, L. (2004) · The Journals of Gerontology Series A: Biological Sciences and Medical Sciences · doi:10.1093/gerona/59.3.m242 · Cited by 901
IL‐10 and TGF‐β cooperate in the regulatory T cell response to mucosal allergens in normal immunity and specific immunotherapy
Jutel, M., Akdiş, M., Budak, F., Aebischer‐Casaulta, C., Wrzyszcz, M., Blaser, K., & Akdiş, C. A. (2003) · European Journal of Immunology · doi:10.1002/eji.200322919 · Cited by 908
Exerkines in health, resilience and disease
Chow, L. S., Gerszten, R. E., Taylor, J. M., Pedersen, B. K., van Praag, H., Trappe, S., Febbraio, M. A., Galis, Z. S., Gao, Y., Haus, J. M., et al. (2022) · Nature Reviews Endocrinology · doi:10.1038/s41574-022-00641-2 · Cited by 927
Biology of interleukin-10
Sabat, R., Grütz, G., Warszawska, K., Kirsch, S., Witte, E., Wolk, K., & Geginat, J. (2010) · Cytokine & Growth Factor Reviews · doi:10.1016/j.cytogfr.2010.09.002 · Cited by 977
lnterleukin-13 is a new human lymphokine regulating inflammatory and immune responses
Minty, A. J., Chalon, P., Derocq, J., Dumont, X., Guillemot, J.-C., Kaghad, M., Labit, C., Leplatois, P., Liauzun, P., Miloux, B., et al. (1993) · Nature · doi:10.1038/362248a0 · Cited by 872
Interleukin 13, an interleukin 4-like cytokine that acts on monocytes and B cells, but not on T cells
Zurawski, G., & de Vries, J. E. (1994) · Immunology Today · doi:10.1016/0167-5699(94)90021-3 · Cited by 872
Emergency granulopoiesis
Manz, M. G., & Boettcher, S. (2014) · Nature Reviews Immunology · doi:10.1038/nri3660 · Cited by 855
TNF signaling inhibition in the CNS: implications for normal brain function and neurodegenerative disease
McCoy, M. K., & Tansey, M. G. (2008) · Journal of Neuroinflammation · doi:10.1186/1742-2094-5-45 · Cited by 870
Protective Role of Interleukin-10 in Atherosclerosis
Mallat, Z., Besnard, S., Duriez, M., Deleuze, V., Emmanuel, F., Bureau, M. F., Soubrier, F., Esposito, B., Duez, H., Fiévet, C., et al. (1999) · Circulation Research · doi:10.1161/01.res.85.8.e17 · Cited by 846
Mechanisms of allergen-specific immunotherapy
Akdiş, C. A., & Akdis, M. (2011) · Journal of Allergy and Clinical Immunology · doi:10.1016/j.jaci.2010.11.030 · Cited by 830
Interleukin 10 reduces the release of tumor necrosis factor and prevents lethality in experimental endotoxemia.
Gerard, C. M., Bruyns, C., Marchant, A., Abramowicz, D., Vandenabeele, P., Delvaux, A., Fiers, W., Goldman, M., & Velu, T. J. (1993) · The Journal of Experimental Medicine · doi:10.1084/jem.177.2.547 · Cited by 786
Interleukin 10 protects mice from lethal endotoxemia.
Howard, M., Muchamuel, T., Andrade, S., & Menon, S. (1993) · The Journal of Experimental Medicine · doi:10.1084/jem.177.4.1205 · Cited by 782
The inflammasome: an integrated view
Gross, O., Thomas, C. J., Guarda, G., & Tschopp, J. (2011) · Immunological Reviews · doi:10.1111/j.1600-065x.2011.01046.x · Cited by 778
Interleukins, from 1 to 37, and interferon-γ: Receptors, functions, and roles in diseases
Akdiş, M., Bürgler, S., Crameri, R., Eiwegger, T., Fujita, H., Alcaide, E. G., Klunker, S., Meyer, N., O’Mahony, L., Palomares, Ó., et al. (2011) · Journal of Allergy and Clinical Immunology · doi:10.1016/j.jaci.2010.11.050 · Cited by 809
Interleukin 12 and tumor necrosis factor alpha are costimulators of interferon gamma production by natural killer cells in severe combined immunodeficiency mice with listeriosis, and interleukin 10 is a physiologic antagonist.
Tripp, C. S., Wolf, S. F., & Unanue, E. R. (1993) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.90.8.3725 · Cited by 768
The adhesion molecule and cytokine profile of multiple sclerosis lesions
Cannella, B., & Raine, C. S. (1995) · Annals of Neurology · doi:10.1002/ana.410370404 · Cited by 759
Cytokines in Sepsis: Potent Immunoregulators and Potential Therapeutic Targets—An Updated View
Schulte, W., Bernhagen, J., & Bucala, R. (2013) · Mediators of Inflammation · doi:10.1155/2013/165974 · Cited by 782
“In vitro, IL-10 suppresses the production of proinflammatory mediators, such as TNF-α, IL-1, IL-6, IFN-γ, and GM-CSF, in immune cells [85, 86].”
Background
Mechanisms of immune suppression by interleukin‐10 and transforming growth factor‐β: the role of T regulatory cells
Taylor, A., Verhagen, J., Blaser, K., Akdis, M., & Akdiş, C. A. (2006) · Immunology · doi:10.1111/j.1365-2567.2006.02321.x · Cited by 747
Inflammatory Mediators of Asthma: An Update
Barnes, P. J., Chung, K. F., & Page, C. P. (1998) · Pharmacological Reviews · doi:10.1016/s0031-6997(24)01381-4 · Cited by 715
The Role of Markers of Inflammation in Traumatic Brain Injury
Woodcock, T. M., & Morganti-Kossmann, M. C. (2013) · Frontiers in Neurology · doi:10.3389/fneur.2013.00018 · Cited by 719
“The IL-1 family includes the closely related agonists IL-1α and IL-1β, the antagonist IL-1ra, and the other family member, the agonist IL-18 (Dinarello, 1994, 1998, 2009; Barksby et al., 2007).”
Background
Interleukin (IL)-10 Inhibits Nuclear Factor кB (NFкB) Activation in Human Monocytes
Wang, P., Wu, P., Siegel, M. I., Egan, R. W., & Billah, M. M. (1995) · Journal of Biological Chemistry · doi:10.1074/jbc.270.16.9558 · Cited by 710
The cytokine network involved in the host immune response to periodontitis
Pan, W., Wang, Q., & Chen, Q. (2019) · International Journal of Oral Science · doi:10.1038/s41368-019-0064-z · Cited by 740
Potential toxicity of polystyrene microplastic particles
Hwang, J., Choi, D., Han, S., Jung, S. Y., Choi, J. H., & Hong, J. (2020) · Scientific Reports · doi:10.1038/s41598-020-64464-9 · Cited by 738
Potential role of interleukin-10-secreting regulatory T cells in allergy and asthma
Hawrylowicz, C. M., & O’Garra, A. (2005) · Nature reviews. Immunology · doi:10.1038/nri1589 · Cited by 706
Interleukin-1 Receptor Antagonist
Arend, W. P. (1993) · Advances in immunology · doi:10.1016/s0065-2776(08)60535-0 · Cited by 670
An assessment of the toxicity of polypropylene microplastics in human derived cells
Hwang, J., Choi, D., Han, S., Choi, J. H., & Hong, J. (2019) · The Science of The Total Environment · doi:10.1016/j.scitotenv.2019.05.071 · Cited by 687
Cytokines in asthma
Chung, K. F., & Barnes, P. J. (1999) · Thorax · doi:10.1136/thx.54.9.825 · Cited by 654
Biological properties of interleukin 10
Howard, M., & O’Garra, A. (1992) · Immunology Today · doi:10.1016/0167-5699(92)90153-x · Cited by 635
TH1 cells control themselves by producing interleukin-10
O’Garra, A., & Vieira, P. (2007) · Nature reviews. Immunology · doi:10.1038/nri2097 · Cited by 614
Synthesis and release of B-lymphocyte stimulator from myeloid cells
Nardelli, B., Belvedere, O., Roschke, V. V., Moore, P. A., Olsen, H. S., Migone, T., Sosnovtseva, S., Carrell, J. A., Feng, P., Giri, J. G., et al. (2001) · Blood · doi:10.1182/blood.v97.1.198 · Cited by 572
Tumour necrosis factor (TNF) gene polymorphism influences TNF-α production in lipopolysaccharide (LPS)-stimulated whole blood cell culture in healthy humans
Louis, E. J., Franchimont, D. P., Piron, A., Gevaert, Y., Schaaf‐Lafontaine, N., Roland, S., Mahieu, P. R., Malaise, M., Groote, D. D., Louis, R. E., et al. (1998) · Clinical & Experimental Immunology · doi:10.1046/j.1365-2249.1998.00662.x · Cited by 575
Dynamic regulation of pro- and anti-inflammatory cytokines by MAPK phosphatase 1 (MKP-1) in innate immune responses
Chi, H., Barry, S. P., Flach, R. J. R., Wu, J. J., Jones, E. A., Bennett, A. M., & Flavell, R. A. (2006) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0510965103 · Cited by 568
Interleukin 13, a T-cell-derived cytokine that regulates human monocyte and B-cell function.
McKenzie, A. N. J., Culpepper, J., Malefyt, R. D. W., Brière, F., Punnonen, J., Aversa, G., Sato, A., Dang, W., Cocks, B. G., & Menon, S. (1993) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.90.8.3735 · Cited by 558
Regulatory Activity of Autocrine IL-10 on Dendritic Cell Functions
Corinti, S., Albanesi, C., la Sala, A., Pastore, S., & Girolomoni, G. (2001) · The Journal of Immunology · doi:10.4049/jimmunol.166.7.4312 · Cited by 555
Interleukin-10 is a central regulator of the response to LPS in murine models of endotoxic shock and the Shwartzman reaction but not endotoxin tolerance.
Berg, D., Kühn, R., Rajewsky, K., Müller, W., Menon, S., Davidson, N. M., Grünig, G., & Rennick, D. M. (1995) · Journal of Clinical Investigation · doi:10.1172/jci118290 · Cited by 536
Interleukin-10 Signaling Blocks Inhibitor of κB Kinase Activity and Nuclear Factor κB DNA Binding
Schottelius, A. J. G., Mayo, M. W., Sartor, R. B., & Baldwin, A. S. (1999) · Journal of Biological Chemistry · doi:10.1074/jbc.274.45.31868 · Cited by 526
Administration of Akkermansia muciniphila Ameliorates Dextran Sulfate Sodium-Induced Ulcerative Colitis in Mice
Bian, X., Wu, W., Yang, L., Lv, L., Wang, Q., Li, Y., Ye, J., Fang, D., Wu, J., Jiang, X., et al. (2019) · Frontiers in Microbiology · doi:10.3389/fmicb.2019.02259 · Cited by 535
“An increase in serum cytokines, including the pro-inflammatory cytokines TNF-α, IL1α, IL6, and IL12A, as well as the chemokines MIP-1A, G-CSF, and KC, was observed in mice administered DSS only (DP vs. CP, Figure 4A).”
BackgroundInfluential
The role of parvovirus B19 in the pathogenesis of giant cell arteritis: A preliminary evaluation
Gabriel, S. E., Espy, M. J., Erdman, D. D., Björnsson, J., Smith, T. F. A., & Hunder, G. G. (1999) · Arthritis & Rheumatism · doi:10.1002/1529-0131(199906)42:6 · Cited by 156
Roles and regulation of the mucus barrier in the gut
Cornick, S., Tawiah, A., & Chadee, K. (2015) · Tissue Barriers · doi:10.4161/21688370.2014.982426 · Cited by 556
“In particular, IL-10 has been shown to regulate the mucus barrier by inhibiting ER stress and protein misfolding.126 IL-10 is a Th2 cytokine with anti-inflammatory functions and also inhibits the synthesis of pro-inflammatory cytokines such as IL-1b, IL-6 and TNFa.162,163 The effect of IL-10 on ER stress was investiga…”
Background
Immunoregulatory role of interleukin 10 in rheumatoid arthritis.
Katsikis, P. D., Chu, C., Brennan, F. M., Maini, R. N., & Feldmann, M. (1994) · The Journal of Experimental Medicine · doi:10.1084/jem.179.5.1517 · Cited by 531
Ly‐1 B (B‐1) cells are the main source of B cell‐derived interleukin 10
O’Garra, A., Chang, R., Go, N. F., Hastings, R., Haughton, G., & Howard, M. (1992) · European Journal of Immunology · doi:10.1002/eji.1830220314 · Cited by 536
Inflammation and its Resolution as Determinants of Acute Coronary Syndromes
Libby, P., Tabas, I. A., Fredman, G., & Fisher, E. A. A. (2014) · Circulation Research · doi:10.1161/circresaha.114.302699 · Cited by 531
Epinephrine inhibits tumor necrosis factor-alpha and potentiates interleukin 10 production during human endotoxemia.
van der Poll, T., Coyle, S. M., Barbosa, K., Braxton, C. C., & Lowry, S. F. (1996) · Journal of Clinical Investigation · doi:10.1172/jci118469 · Cited by 514
Contrasting mechanisms for suppression of macrophage cytokine release by transforming growth factor-beta and interleukin-10
Bogdan, C., Paik, J., Yoram Vodovotz, B., & Nathan, C. (1992) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(18)50091-0 · Cited by 502
Interleukin-10–Treated Human Dendritic Cells Induce a Melanoma-Antigen–Specific Anergy in CD8+ T Cells Resulting in a Failure to Lyse Tumor Cells
Steinbrink, K., Jonuleit, H., Müller, G., Schuler, G., Knop, J., & Enk, A. (1999) · Blood · doi:10.1182/blood.v93.5.1634 · Cited by 509
Interleukin 10 (IL-10) inhibits the release of proinflammatory cytokines from human polymorphonuclear leukocytes. Evidence for an autocrine role of tumor necrosis factor and IL-1 beta in mediating the production of IL-8 triggered by lipopolysaccharide.
Cassatella, M. A., Meda, L., Bonora, S., Ceska, M., & Constantin, G. (1993) · The Journal of Experimental Medicine · doi:10.1084/jem.178.6.2207 · Cited by 501
Interleukin-6 in the Injured Patient
Biffl, W. L., Moore, E. E., Moore, F. A., & Peterson, V. M. (1996) · Annals of Surgery · doi:10.1097/00000658-199611000-00009 · Cited by 502
Properties and Functions of Interleukin-10
Mosman, T. R. (1994) · Advances in immunology · doi:10.1016/s0065-2776(08)60449-6 · Cited by 495
Interleukin-10 regulation in normal subjects and patients with asthma
Borish, L., Aarons, A., Rumbyrt, J., Cvietusa, P. J., Negri, J. A., & Wenzel, S. E. (1996) · Journal of Allergy and Clinical Immunology · doi:10.1016/s0091-6749(96)70197-5 · Cited by 489
Pathogenesis and Pathophysiology of Pneumococcal Meningitis
Mook-Kanamori, B. B., Geldhoff, M., van der Poll, T., & van de Beek, D. (2011) · Clinical Microbiology Reviews · doi:10.1128/cmr.00008-11 · Cited by 492
Augmentation of naive, Th1 and Th2 effector CD4 Responses by IL-6, IL-1 and TNF
Joseph, S. B., Miner, K. T., & Croft, M. (1998) · European Journal of Immunology · doi:10.1002/(sici)1521-4141(199801)28:01 · Cited by 100
Anti‐inflammatory effects of sodium butyrate on human monocytes: potent inhibition of IL‐12 and up‐regulation of IL‐10 production
Säemann, M. D., Böhmig, G. A., Österreicher, C. H., BURTSCHER, H. J., Parolini, O., Diakos, C., Stöckl, J., Hörl, W. H., & Zlabinger, G. J. (2000) · The FASEB Journal · doi:10.1096/fj.00-0359fje · Cited by 482
Hemoglobin Scavenger Receptor CD163 Mediates Interleukin-10 Release and Heme Oxygenase-1 Synthesis: Antiinflammatory Monocyte-Macrophage Responses In Vitro, in Resolving Skin Blisters In Vivo, and After Cardiopulmonary Bypass Surgery
Philippidis, P., Mason, J. C., Evans, B. J., Nadra, I., Taylor, K. M., Haskard, D. O., & Landis, R. C. (2004) · Circulation Research · doi:10.1161/01.res.0000109414.78907.f9 · Cited by 476
Role of interferons and other cytokines in the regulation of the immune response
Belardelli, F. (1995) · Apmis · doi:10.1111/j.1699-0463.1995.tb01092.x · Cited by 471
Changes in interleukin-2 and interleukin-4 production in asymptomatic, human immunodeficiency virus-seropositive individuals.
Clerici, M., Hakim, F. T., Venzon, D. J., Blatt, S., Hendrix, C. W., Wynn, T. A., & Shearer, G. M. (1993) · Journal of Clinical Investigation · doi:10.1172/jci116294 · Cited by 469
Interleukin 10 secretion in relation to human IL-10 locus haplotypes
Eskdale, J., Gallagher, G. E., Verweij, C. L., Keijsers, V., Westendorp, R. G. J., & Huizinga, T. W. J. (1998) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.95.16.9465 · Cited by 466
Remnants of suicidal cells fostering systemic autoaggression: Apoptosis in the origin and maintenance of autoimmunity
Rovere, P. Q., Sabbadini, M. G., Fazzini, F., Bondanza, A., Zimmermann, V. S., Rugarli, C., & Manfredi, A. A. (2000) · Arthritis & Rheumatism · doi:10.1002/1529-0131(200008)43:8 · Cited by 85
Enhancing Effect of IL-17 on IL-1-Induced IL-6 and Leukemia Inhibitory Factor Production by Rheumatoid Arthritis Synoviocytes and Its Regulation by Th2 Cytokines
Chabaud, M., Fossiez, F., Taupin, J., & Miossec, P. (1998) · The Journal of Immunology · doi:10.4049/jimmunol.161.1.409 · Cited by 457
Cytokines and macrophages
Cavaillon, J. (1994) · Biomedicine & Pharmacotherapy · doi:10.1016/0753-3322(94)90005-1 · Cited by 453
Mechanism of endotoxin desensitization: involvement of interleukin 10 and transforming growth factor beta.
Randow, F., Syrbe, U., Meisel, C., Krausch, D., Zuckermann, H., Platzer, C., & Volk, H. (1995) · The Journal of Experimental Medicine · doi:10.1084/jem.181.5.1887 · Cited by 446
Adipose Tissue-Derived Multipotent Stromal Cells Have a Higher Immunomodulatory Capacity Than Their Bone Marrow-Derived Counterparts
Melief, S. M., Zwaginga, J. J., Fibbe, W. E., & Roelofs, H. (2013) · Stem Cells Translational Medicine · doi:10.5966/sctm.2012-0184 · Cited by 442
IL‐10 inhibits macrophage activation and proliferation by distinct signaling mechanisms: evidence for Stat3‐dependent and ‐independent pathways
O’Farrell, A.-M., Liu, Y., Moore, K. W., & Mui, A. L. ‐. (1998) · The EMBO Journal · doi:10.1093/emboj/17.4.1006 · Cited by 440
Inhibition of Pro-inflammatory Markers in Primary Bone Marrow-Derived Mouse Macrophages by Naturally Occurring Flavonoids: Analysis of the Structure-Activity Relationship
Comalada, M., Ballester, I., Bailón, E., Sierra, S., Xaus, J., Gálvez, J., Medina, F. S. D., & Zarzuelo, A. (2006) · Biochemical Pharmacology · doi:10.1016/j.bcp.2006.07.016 · Cited by 440
The microbicidal activity of interferon‐γ‐treated macrophages against Trypanosoma cruzi involves an L‐arginine‐dependent, nitrogen oxide‐mediated mechanism inhibitable by interleukin‐10 and transforming growth factor‐β
Gazzinelli, R. T., Oswald, I. P., Hieny, S. E., James, S. L., & Sher, A. (1992) · European Journal of Immunology · doi:10.1002/eji.1830221006 · Cited by 429
Interleukin 10 production correlates with pathology in human Leishmania donovani infections.
Ghalib, H. W., Piuvezam, M. R., Skeiky, Y. A. W., Siddig, M., Hashim, F. A., El-Hassan, A. M., Russo, D., & Reed, S. G. (1993) · Journal of Clinical Investigation · doi:10.1172/jci116570 · Cited by 434
IL-10 inhibits metalloproteinase and stimulates TIMP-1 production in human mononuclear phagocytes.
Lacraz, S. F., Nicod, L. P., Chicheportiche, R., Welgus, H. G., & Dayer, J. (1995) · Journal of Clinical Investigation · doi:10.1172/jci118286 · Cited by 430
Cross-regulatory roles of interleukin (IL)-12 and IL-10 in atherosclerosis.
Uyemura, K., Demer, L. L., Castle, S. C., Jullien, D., Berliner, J. A., Gately, M. K., Warrier, R. R., Pham, N., Fogelman, A. M., & Modlin, R. L. (1996) · Journal of Clinical Investigation · doi:10.1172/jci118650 · Cited by 427
The Cytokine Profile Expressed by Human Dendritic Cells Is Dependent on Cell Subtype and Mode of Activation
de Saint-Vis, B., Vivier, I., Massacrier, C., Gaillard, C., Vanbervliet, B., Aït‐Yahia, S., Banchereau, J., Liu, Y., Lebecque, S., & Caux, C. (1998) · The Journal of Immunology · doi:10.4049/jimmunol.160.4.1666 · Cited by 427
B cells responses and cytokine production are regulated by their immune microenvironment
Vazquez, M. I., Catalan-Dibene, J., & Zlotnik, A. (2015) · Cytokine · doi:10.1016/j.cyto.2015.02.007 · Cited by 421
“It can also down-regulate MHC class II expression on immune cells [78].”
Background
IL-10 is a key cytokine in psoriasis. Proof of principle by IL-10 therapy: a new therapeutic approach.
Asadullah, K., Sterry, W., Stephanek, K., Jasulaitis, D., Leupold, M., Audring, H., Volk, H., & Döcke, W. D. (1998) · Journal of Clinical Investigation · doi:10.1172/jci1476 · Cited by 413
High levels of interleukin 10 production in vivo are associated with tolerance in SCID patients transplanted with HLA mismatched hematopoietic stem cells.
Bacchetta, R., Bigler, M., Touraine, J. L., Parkman, R., Tovo, P., Abrams, J. S., Malefyt, R. D. W., de Vries, J. E., & Roncarolo, M. (1994) · The Journal of Experimental Medicine · doi:10.1084/jem.179.2.493 · Cited by 415
Self-citation
The Interleukin-10 Signal Transduction Pathway and Regulation of Gene Expression in Mononuclear Phagocytes
Donnelly, R. P., Dickensheets, H. L., & Finbloom, D. S. (1999) · Journal of Interferon & Cytokine Research · doi:10.1089/107999099313695 · Cited by 412
IL-10 selectively induces HLA-G expression in human trophoblasts and monocytes
Moreau, P., Cabestré, F. A., Menier, C., Guiard, V., Gourand, L., Dausset, J. B., Carosella, E. D., & Paul, P. (1999) · International Immunology · doi:10.1093/intimm/11.5.803 · Cited by 409
Regulation of serum amyloid A protein expression during the acute-phase response
Jensen, L. E., & Whitehead, A. S. (1998) · Biochemical Journal · doi:10.1042/bj3340489 · Cited by 409
Cytokine regulation of T-cell function: potential for therapeutic intervention
Powrie, F. M., & Coffman, R. L. (1993) · Immunology Today · doi:10.1016/0167-5699(93)90044-l · Cited by 406

Authors: de Waal Malefyt, R., Abrams, J., Bennett, B., Figdor, C. G., & de Vries, J. E.
Affiliations: Department of Human Immunology, DNAX Research Institute, Palo Alto, California 94304.
ORCID: Figdor, C G
Venue: The Journal of experimental medicine
Publisher: Rockefeller University Press
Published: 1991-11-01
Volume: 174
Issue: 5
Pages: 1209-1220
ISSN: 0022-1007 (ISSN-L)
1540-9538
DOI: 10.1084/jem.174.5.1209
PMC: PMC2119001
OpenAlex: W2191654227
Cited by: 3,762
References: 41
Citations by year: 2026: 25 · 2025: 41 · 2024: 45 · 2023: 60 · 2022: 58 · 2021: 68 · 2020: 67 · 2019: 80 · 2018: 69 · 2017: 71 · 2016: 97 · 2015: 98 · 2014: 132 · 2013: 107 · 2012: 122
FWCI: 39.70
Type: journal article
Language: en
Open access: green
www.ncbi.nlm.nih.gov
Licence: cc-by-nc-sa
Locations: The Journal of Experimental Medicine (publishedVersion)
PubMed Central (publishedVersion, cc-by-nc-sa)
PubMed (publishedVersion)
Radboud Repository (Radboud University) (submittedVersion)
Radboud Repository (Radboud University) (submittedVersion, other-oa)
Topics: Life Sciences › Immunology and Microbiology › Immunology › Cytokine Signaling Pathways and Interactions
Life Sciences › Immunology and Microbiology › Immunology › Immune Response and Inflammation
Life Sciences › Immunology and Microbiology › Immunology › Immune cells in cancer
Keywords: IL-10, monocytes, cytokine synthesis inhibition, lipopolysaccharide stimulation, interferon-gamma, autoregulation, cytokine gene expression, MHC class II expression, viral IL-10, TNF-α, GM-CSF, granulocyte colony-stimulating factor, interleukin-6, interleukin-8
MeSH terms: Histocompatibility Antigens Class II, Base Sequence, Cells, Cultured, Homeostasis, Humans, Interferon-gamma, Interleukin-1, Lipopolysaccharides, Molecular Sequence Data, Monocytes, RNA, Messenger, Transcription, Genetic, Interleukin-4, Interleukin-6, Granulocyte-Macrophage Colony-Stimulating Factor, Cytokines, Transforming Growth Factor beta, Interleukin-10

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

Interleukin 10(IL-10) inhibits cytokine synthesis by human monocytes: an autoregulatory role of IL-10 produced by monocytes.

Abstract

Overview

Integrity signals

Verification

Claims the paper makes

Claims other papers make about this one

Self-check

Citations

Cites

Cited by

Related

Metadata

Record

About these checks